{
  "url": "https://openlegislation.uk/medicines-sale-or-supply-miscellaneous-provisions-amendment-regulations-2007/note",
  "json_url": "https://openlegislation.uk/medicines-sale-or-supply-miscellaneous-provisions-amendment-regulations-2007/note.json",
  "legislation": "uksi/2007/2179",
  "legislation_title": "The Medicines (Sale or Supply) (Miscellaneous Provisions) Amendment Regulations 2007",
  "legislation_url": "https://openlegislation.uk/medicines-sale-or-supply-miscellaneous-provisions-amendment-regulations-2007",
  "path": "note",
  "kind": "note",
  "number": null,
  "heading": "Explanatory note",
  "text": "(This note is not part of the Regulations)\nThese Regulations further amend the Medicines (Sale or Supply) (Miscellaneous Provisions) Regulations 1980 (“the principal Regulations”) which impose restrictions on the sale and supply of medicinal products for human use.\nRegulation 5 of, and Schedule 1 to, the principal Regulations specify persons to whom medicinal products may be sold or supplied by way of wholesale dealing, including authorities carrying on the business of an independent hospital, clinic or medical agency. Regulation 2 of these Regulations amends regulation 1 of the principal Regulations to extend the provisions to include independent hospitals, clinics and medical agencies in Northern Ireland. Regulations 2 and 4 amend regulation 1 of, and Schedule 1 to, the principal Regulations to include nursing homes in Northern Ireland.\nRegulation 6 of the principal Regulations imposes requirements regarding the records to be kept by retail pharmacies. Regulation 6(3) imposes a requirement on persons conducting a retail pharmacy business to retain prescriptions, other than “health prescriptions”, for a period of two years. Regulation 3 of these Regulations amends regulation 6(3) to provide an exemption from this requirement in relation to controlled drugs specified under the Misuse of Drugs Regulations 2001. Regulation 3 also amends regulation 6 to substitute references to the current legislation on misuse of drugs.\nA full regulatory impact assessment of the effect that this instrument will have on the costs of business is available from the Medicines and Healthcare products Regulatory Agency, Market Towers, 1 Nine Elms Lane, London SW8 5NQ. Copies of the assessment have been placed in the libraries of both Houses of Parliament.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2007/2179/note",
    "retrieved_at": "2026-10-29T03:47:03.997870+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}